marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q2
added 08-15-2024
Titan Pharmaceuticals Balance Sheet 2011-2024 | TTNP
Annual Balance Sheet Titan Pharmaceuticals
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-2.75 M | -5.74 M | -4.94 M | -782 K | -4.98 M | -938 K | -14 M | -7.86 M | -15.5 M | -11.8 M | -6.24 M | 6.85 M | |
Long Term Debt |
- | 65 K | 187 K | 327 K | 4.02 M | 3.79 M | 3.58 M | - | - | - | - | 9.36 M | 12.3 M |
Long Term Debt Current |
65 K | 122 K | 112 K | 150 K | 272 K | 527 K | 3 M | - | - | - | - | 2.5 M | - |
Total Non Current Liabilities |
- | - | - | 327 K | 4.49 M | 3.81 M | 3.58 M | 619 K | 1.44 M | 5.58 M | 1.82 M | 26.6 M | 25.2 M |
Total Current Liabilities |
1.44 M | 2.63 M | 2.67 M | 4.22 M | 3.6 M | 3.45 M | 4.46 M | 4.86 M | 4.85 M | 6.66 M | 10.8 M | 21.4 M | 5.12 M |
Total Liabilities |
1.44 M | 2.7 M | 2.86 M | 4.56 M | 8.09 M | 7.26 M | 8.05 M | 5.48 M | 6.3 M | 12.2 M | 12.7 M | 48 M | 30.3 M |
Deferred Revenue |
- | - | - | - | - | 313 K | - | - | - | 1.67 M | 5.32 M | 14.4 M | - |
Retained Earnings |
-392 M | -386 M | -376 M | - | -349 M | -333 M | -323 M | -309 M | -314 M | -303 M | -300 M | -310 M | -295 M |
Total Assets |
8.09 M | 4.06 M | 7.99 M | 8.09 M | 9.52 M | 14.1 M | 8.9 M | 18.7 M | 13.3 M | 20.9 M | 18.4 M | 24.8 M | 10.2 M |
Cash and Cash Equivalents |
6.76 M | 2.94 M | 6.04 M | 5.41 M | 5.22 M | 9.3 M | 7.52 M | 14 M | 7.86 M | 15.5 M | 11.8 M | 18.1 M | 5.41 M |
Book Value |
6.64 M | 1.36 M | 5.14 M | 3.53 M | 1.43 M | 6.83 M | 857 K | 13.2 M | 6.99 M | 8.61 M | 5.76 M | -23.1 M | -20.1 M |
Total Shareholders Equity |
6.64 M | 1.36 M | 5.14 M | 3.53 M | 1.43 M | 6.83 M | 857 K | 13.2 M | 6.99 M | 8.61 M | 5.76 M | -23.1 M | -20.1 M |
All numbers in USD currency
Quarterly Balance Sheet Titan Pharmaceuticals
| 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
- | - | - | - | - | 33 K | 65 K | 96 K | 128 K | 158 K | 187 K | - | - | 88 K | 332 K | 332 K | 332 K | 332 K | 4.02 M | 4.02 M | 4.02 M | 4.02 M | 3.79 M | 3.79 M | 3.79 M | 3.79 M | 3.58 M | 3.58 M | 3.58 M | 3.58 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 9.36 M | 9.36 M | 9.36 M | 9.36 M | 12.3 M | 12.3 M | 12.3 M | 12.3 M |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
356 K | 559 K | 1.44 M | 1.87 M | 1.85 M | 2.48 M | 2.7 M | 2.73 M | 2.65 M | 2.44 M | 2.86 M | 2.14 M | 2.76 M | 3.84 M | 4.56 M | 4.56 M | 4.56 M | 4.56 M | 8.09 M | 8.09 M | 8.09 M | 8.09 M | 7.26 M | 7.26 M | 7.26 M | 7.26 M | 8.05 M | 8.05 M | 8.05 M | 8.05 M | 5.48 M | 5.48 M | 5.48 M | 5.48 M | 6.3 M | 6.3 M | 6.3 M | 6.3 M | 12.2 M | 12.2 M | 12.2 M | 12.2 M | 12.7 M | 12.7 M | 12.7 M | 12.7 M | 48 M | 48 M | 48 M | 48 M | 30.3 M | 30.3 M | 30.3 M | 30.3 M |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 313 K | 626 K | 939 K | 313 K | - | - | - | - | - | - | - | - | - | - | - | 760 K | 1.67 M | 1.67 M | 1.67 M | 1.67 M | 5.32 M | 5.32 M | 5.32 M | 5.32 M | 14.4 M | 14.4 M | 14.4 M | 14.4 M | - | - | - | - |
Retained Earnings |
-395 M | -393 M | -392 M | -390 M | -390 M | -388 M | -386 M | -384 M | -381 M | -379 M | -376 M | -374 M | -372 M | -370 M | -367 M | -367 M | -367 M | -367 M | -349 M | -349 M | -349 M | -349 M | -333 M | -333 M | -333 M | -333 M | -323 M | -323 M | -323 M | -323 M | -309 M | -309 M | -309 M | -309 M | -314 M | -314 M | -314 M | -314 M | -303 M | -303 M | -303 M | -303 M | -300 M | -300 M | -300 M | -300 M | -310 M | -310 M | -310 M | -310 M | -295 M | -295 M | -295 M | -295 M |
Total Assets |
4.35 M | 6.65 M | 8.09 M | 10 M | 812 K | 2.17 M | 4.06 M | 6.28 M | 8.32 M | 10.3 M | 7.99 M | 9.64 M | 11.5 M | 13.8 M | 8.09 M | 8.09 M | 8.09 M | 8.09 M | 9.52 M | 9.52 M | 9.52 M | 9.52 M | 14.1 M | 14.1 M | 14.1 M | 14.1 M | 8.9 M | 8.9 M | 8.9 M | 8.9 M | 18.7 M | 18.7 M | 18.7 M | 18.7 M | 13.3 M | 13.3 M | 13.3 M | 13.3 M | 20.9 M | 20.9 M | 20.9 M | 20.9 M | 18.4 M | 18.4 M | 18.4 M | 18.4 M | 24.8 M | 24.8 M | 24.8 M | 24.8 M | 10.2 M | 10.2 M | 10.2 M | 10.2 M |
Cash and Cash Equivalents |
4.09 M | 6.16 M | 6.76 M | 8.1 M | 105 K | 1.14 M | 2.94 M | 4.45 M | 6.42 M | 8.14 M | 6.04 M | 7.42 M | 9.68 M | 11.6 M | 5.41 M | 5.41 M | 5.41 M | 5.41 M | 5.22 M | 5.22 M | 5.22 M | 5.22 M | 9.3 M | 9.3 M | 9.3 M | 9.3 M | 7.52 M | 7.52 M | 7.52 M | 7.52 M | 14 M | 14 M | 14 M | 14 M | 7.86 M | 7.86 M | 7.86 M | 7.86 M | 15.5 M | 15.5 M | 15.5 M | 15.5 M | 11.8 M | 11.8 M | 11.8 M | 11.8 M | 18.1 M | 18.1 M | 18.1 M | 18.1 M | 5.41 M | 5.41 M | 5.41 M | 5.41 M |
Book Value |
3.99 M | 6.09 M | 6.64 M | 8.13 M | -1.03 M | -312 K | 1.36 M | 3.55 M | 5.67 M | 7.88 M | 5.14 M | 7.5 M | 8.75 M | 9.98 M | 3.53 M | 3.53 M | 3.53 M | 3.53 M | 1.43 M | 1.43 M | 1.43 M | 1.43 M | 6.83 M | 6.83 M | 6.83 M | 6.83 M | 857 K | 857 K | 857 K | 857 K | 13.2 M | 13.2 M | 13.2 M | 13.2 M | 6.99 M | 6.99 M | 6.99 M | 6.99 M | 8.61 M | 8.61 M | 8.61 M | 8.61 M | 5.76 M | 5.76 M | 5.76 M | 5.76 M | -23.1 M | -23.1 M | -23.1 M | -23.1 M | -20.1 M | -20.1 M | -20.1 M | -20.1 M |
Total Shareholders Equity |
3.99 M | 6.09 M | 6.64 M | 8.13 M | -1.03 M | -312 K | 1.36 M | 3.55 M | 5.67 M | 7.88 M | 5.14 M | 7.5 M | 8.75 M | 9.98 M | 3.53 M | 3.53 M | 3.53 M | 3.53 M | 1.43 M | 1.43 M | 1.43 M | 1.43 M | 6.83 M | 6.83 M | 6.83 M | 6.83 M | 857 K | 857 K | 857 K | 857 K | 13.2 M | 13.2 M | 13.2 M | 13.2 M | 6.99 M | 6.99 M | 6.99 M | 6.99 M | 8.61 M | 8.61 M | 8.61 M | 8.61 M | 5.76 M | 5.76 M | 5.76 M | 5.76 M | -23.1 M | -23.1 M | -23.1 M | -23.1 M | -20.1 M | -20.1 M | -20.1 M | -20.1 M |
All numbers in USD currency